Addictions and Opioid Agonist Therapy Education
Update your methadone training requirements a minimum of every five years with this approved program that is aligned with the Ontario College of Pharmacists guidelines for pharmacists dispensing methadone.
$0.00
Description
Description:
Pharmacists can play an important role when providing maintenance treatment to patients with an opioid addiction. This collection of modules will provide you with useful information and training on how to best manage and treat opioid addictions. It will focus on OAT by providing an overview on buprenorphine, methadone and naloxone, the three most common medications used in the treatment of opioid addiction.
It will provide pharmacists with the knowledge they need to confidently guide and counsel opioid users in pharmacy.
This course satisfies the requirements for training updates. For more information, please see Key Requirements for Methadone Maintenance Treatment (MMT).
Learning Objectives:
- Identify risk factors for opioid use disorder and pain management options for patients in opioid agonist therapy
- Know and identify the policies that pharmacists should refer to when dispensing methadone in Ontario
- Identify the pharmacist’s role in harm reduction
- Apply knowledge and discuss the pharmacist’s role in dealing with opioid cases
Course Outline:
Mandatory Module
-
Policies Guiding Methadone Dispensing in Ontario
Optional Modules
-
Canadian National Consensus Guidelines on Naloxone
-
Chronic Pain Management Part 1 – Opioid Pharmacotherapy
-
Chronic Pain Management Part 2 – Nonopioid Pharmacotherapy
-
Compassion in Practice: Overcoming Stigma in Addictions Care
-
Demystifying Psychedelics: An Overview for Pharmacists
-
Frontline Perspectives: Building Trust in Substance Use Health
-
Guidance for Safer Opioid Dispensing for Pharmacists
-
Hepatitis C: An Opportunity We Cannot Afford to Miss
-
Introduction to Methadone Dispensing Requirements in Ontario
-
Ketamine: Gamechanger or Placeholder?
-
Motivational Interviewing
-
Navigating Patient Cases in OAT
-
New options in OAT - Long-acting Buprenorphine Formulations
-
Operationalizing Ontario’s Patch-for-Patch Fentanyl Return Program
-
Opioid Agonist Therapy in Pregnancy and Breastfeeding
-
Opioid Use Disorder Treatment: A 2023 Update
-
Providing Inclusive Care for LGBTQ+ Patients
-
Slow Release Oral Morphine in OAT: Evolving Options for OUD
-
Supporting the Mental Health and Wellness of Indigenous Peoples
-
Take-home Naloxone Program in Community Pharmacies
-
Trauma Informed Care
-
We are People First
-
(Unknown) Polysubstance Use and Exposure
Course at a Glance:
- Course expiry date: March 31, 2027
- Accreditation: This course is unaccredited
- Online
- Completion requirement: Complete the mandatory module plus 4 optional modules of your choosing, the declaration of completion, and the program evaluation before the expiry date to receive a letter of completion.
Intended Audience:
Successful completion of this course qualifies as an approved training course as part of their training update for pharmacists dispensing methadone. Updates are required at minimum every five years as indicated in the Ontario College of Pharmacists’ Opioid Policy. Please note that this course does not replace the CAMH Opioid Use Disorder (OUDT) course, which Designated Managers and pharmacists are required to complete to dispense methadone as outlined in the Ontario College of Pharmacists’ Opioid Policy. This course is open and applicable to all pharmacy professionals including students and pharmacy technicians. Any pharmacy professionals who are interested in or currently dispensing methadone make find the content useful to their practice.
Development Team:
- Rose Fitzgerald, BScPhm, RPh
- Karen Ng, BScPhm, ACPR, Pharm D, RPh
- Candace Necyk, BScPhm, MSc, PhD
- Shawn Fisk, CACC
- Vikas Parihar, PharmD, BScPhm , RPh
- Jordan J. Feld, MD, MPH
- Laura Murphy, PharmD, ACPR, RPh
- Michael A. Beazely, BSP, PhD
- Juno Kim, BSc, BScPhm, PharmD, RPh
- Jenny Jiang, HBScPhm, MBA, RPh
- Maria Zhang, BScPhm, PharmD, MSc, RPh
- Dr. Maurice Agha, MD, BSc, CCFP, CISAM, CCSAM
- Tianna Costa, PharmD, ACPR, RPh
- James Morrison, BSc, BScPhm, CDE, RPh
- Dr. Jaris Swidrovich, BSP, PharmD, PhD©m AAHIVP, RPh
- Dr. Gezina Baehr, PharmD, RPh
- Kathleen Leach, RPh
- Aviral Dube, RPh, PharmD, CDE
- Ivana Jankovic, RPh, BSc Phm, PharmD
Our Commitment:
OPA is committed to providing high-quality, accurate, and unbiased educational content, tools, and resources for healthcare professionals and patients. Learn more about our process for content development and our firm commitment to maintaining content integrity here.
Sponsor:
This course is supported by funding from the Mental Health and Addiction Centre of Excellence of Ontario Health.
OPA programs you may also like
-
- Sale!
- UofW Prescribing for Minor Ailments – Full 19 Conditions
-
$279.00$229.00
